Skip to main content
Caplight Logo









MOLEQLAR

MOLEQLAR

Private
BerlinConsumer & Commercehttps://moleqlar.com/

Last Round

Seed

Nov 9, 2023

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MOLEQLAR is a biotechnology and food company that develops and distributes science-based longevity products including nutritional supplements and health tests.

Sector

Consumer & Commerce

Verticals

D2C Brands, Subscription Commerce, Precision Medicine, Biotechnology, E-commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

longevitylongevity supplementsat-home health testsbiological age testbiohackingNAD testNMN supplementepigeneticspersonalized supplementspreventative healthspermidine supplementDTCsubscription commercecorporate healthchemicals for research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MOLEQLAR Comparables

Compare MOLEQLAR with similar companies based on industry and business-model similarity.

MOLEQLAR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Purovitalis
88%
AVEA Life
85%
DoNotAge
85%

MOLEQLAR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 9, 2023

Key People

Founding team and executive leadership

Clemens Klingler

Co-Founder And COO

Founding Team

Mario Gietl

Co-Founder & CMO

Founding Team

Max Griessinger

CEO & Founder

Founding Team

MOLEQLAR Investors

Notable investors and investment history

MOLEQLAR investors
InvestorRounds
Rheingau FoundersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 25, 156% of headcount.

  • Jun 15, 2026

    Open roles increased from 0 to 4, representing 25% of headcount.

MOLEQLAR Filings

Explore SEC and related filing metadata, where available.

MOLEQLAR filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MOLEQLAR's valuation, stock price, and market status.

Is MOLEQLAR a public or private company?

MOLEQLAR is a private company.

What is the current stock price of MOLEQLAR?

MOLEQLAR is a private company with no public stock price. No recent secondary market data is available.

How much is MOLEQLAR worth (valuation)?

Valuation information for MOLEQLAR is not publicly available.

Can I buy MOLEQLAR stock?

MOLEQLAR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MOLEQLAR's last funding round?

MOLEQLAR's most recent funding round was Seed on November 9, 2023.

Who are the main investors in MOLEQLAR?

Key investors in MOLEQLAR include Rheingau Founders.

Will MOLEQLAR IPO soon?

No public IPO plans have been announced for MOLEQLAR.

How can I track MOLEQLAR secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MOLEQLAR's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range16
Year Founded2020
Last FundingNov 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?